Cargando…

Reasons for Ineligibility in Phase 1 and 2A HIV Vaccine Clinical Trials at Kenya Aids Vaccine Initiative (KAVI), Kenya

BACKGROUND: With the persistent challenges towards controlling the HIV epidemic, there is an ongoing need for research into HIV vaccines and drugs. Sub-Saharan African countries - worst affected by the HIV pandemic - have participated in the conduct of clinical trials for HIV vaccines. In Kenya, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Omosa-Manyonyi, Gloria S., Jaoko, Walter, Anzala, Omu, Ogutu, Hilda, Wakasiaka, Sabina, Malogo, Roselyn, Nyange, Jacqueline, Njuguna, Pamela, Ndinya-Achola, Jeckoniah, Bhatt, Kirana, Farah, Bashir, Oyaro, Micah, Schmidt, Claudia, Priddy, Frances, Fast, Patricia
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024980/ https://www.ncbi.nlm.nih.gov/pubmed/21283743 http://dx.doi.org/10.1371/journal.pone.0014580

Ejemplares similares

Acceptability of Medical Male Circumcision Among Uncircumcised Men in Kenya One Year After the Launch of the National Male Circumcision Program
por: Herman-Roloff, Amy, et al.
Publicado: (2011)

Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya
por: Omosa-Manyonyi, Gloria, et al.
Publicado: (2014)

Spatial distribution and cluster analysis of sexual risk behaviors reported by young men in Kisumu, Kenya
por: Westercamp, Nelli, et al.
Publicado: (2010)

Willingness to participate in future HIV vaccine trials among men who have sex with men and female sex workers living in Nairobi, Kenya
por: Mutisya, Elizabeth Mueni, et al.
Publicado: (2020)

Implementing Voluntary Medical Male Circumcision for HIV Prevention in Nyanza Province, Kenya: Lessons Learned during the First Year
por: Herman-Roloff, Amy, et al.
Publicado: (2011)

Uptake and tolerability of repeated mucosal specimen collection in two Phase 1 AIDS preventive vaccine trials in Kenya
por: Mutua, G, et al.
Publicado: (2012)

Reported willingness to participate in a hypothetical HIV vaccine trial and its translation to actual participation among healthy adults—Experience from Kenya
por: Nyasani, Delvin Kwamboka, et al.
Publicado: (2018)

Multidrug-Resistant Bacterial Isolates Recovered from Herbal Medicinal Products Sold in Nairobi, Kenya
por: Korir, Richard, et al.
Publicado: (2017)

Widow Inheritance and HIV Prevalence in Bondo District, Kenya: Baseline Results from a Prospective Cohort Study
por: Agot, Kawango E., et al.
Publicado: (2010)

Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya
por: Nyaoke, Borna A., et al.
Publicado: (2017)

Urinary interleukins (IL)-6 and IL-10 in schoolchildren from an area with low prevalence of Schistosoma haematobium infections in coastal Kenya
por: Njaanake, Kariuki H., et al.
Publicado: (2023)

Using a multimethod approach to develop implementation strategies for a cervical self-sampling program in Kenya
por: Podolak, Irene, et al.
Publicado: (2017)

Seasonal influenza vaccination in Kenya: an economic evaluation using dynamic transmission modelling
por: Dawa, Jeanette, et al.
Publicado: (2020)

Assessment of hepatitis B vaccination status and hepatitis B surface antibody titres among health care workers in selected public health hospitals in Kenya
por: Mwangi, Irene Ann, et al.
Publicado: (2023)

Loss to Follow-Up as a Competing Risk in an Observational Study of HIV-1 Incidence
por: Graham, Susan M., et al.
Publicado: (2013)

Prevalence and risk factors of three curable sexually transmitted infections among women in Nairobi, Kenya
por: Maina, Anne Njeri, et al.
Publicado: (2016)

Hepatitis B status and associated factors among participants screened for simulated HIV vaccine efficacy trials in Kenya and Uganda
por: Mayanja, Yunia, et al.
Publicado: (2023)

Latent tuberculosis among household contacts of pulmonary tuberculosis cases in Nairobi, Kenya
por: Odera, Susan, et al.
Publicado: (2020)

“When I Was Circumcised I Was Taught Certain Things”: Risk Compensation and Protective Sexual Behavior among Circumcised Men in Kisumu, Kenya
por: Riess, Thomas H., et al.
Publicado: (2010)

Cancer in Kenya: types and infection-attributable. Data from the adult population of two National referral hospitals (2008-2012)
por: Macharia, Lucy Wanjiku, et al.
Publicado: (2019)

Safety and Immunogenicity of a 2-Dose Heterologous Vaccine Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Nairobi, Kenya
por: Mutua, Gaudensia, et al.
Publicado: (2019)

National burden of hospitalized and non‐hospitalized influenza‐associated severe acute respiratory illness in Kenya, 2012‐2014
por: Dawa, Jeanette A., et al.
Publicado: (2017)

Risk Compensation Is Not Associated with Male Circumcision in Kisumu, Kenya: A Multi-Faceted Assessment of Men Enrolled in a Randomized Controlled Trial
por: Mattson, Christine L., et al.
Publicado: (2008)

Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya
por: Mugo, Peter Mwangi, et al.
Publicado: (2014)

Mucosal Blood Group Antigen Expression Profiles and HIV Infections: A Study among Female Sex Workers in Kenya
por: Chanzu, Nadia Musimbi, et al.
Publicado: (2015)

Cultured enzyme-linked immunospot assay (ELISPOT) enhances detection of low HIV-specific immune responses in exposed seronegative individuals in Kenya
por: Muturi, Margaret, et al.
Publicado: (2006)

Evaluation and optimization of the syndromic management of female genital tract infections in Nairobi, Kenya
por: Omosa-Manyonyi, Gloria S., et al.
Publicado: (2023)

A prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy
por: Masese, Linnet N, et al.
Publicado: (2011)

Performance of International AIDS Vaccine Initiative African clinical research laboratories in standardised ELISpot and peripheral blood mononuclear cell processing in support of HIV vaccine clinical trials
por: Langat, Robert K., et al.
Publicado: (2021)

Aflatoxin exposure in children age 6–12 years: a study protocol of a randomized comparative cross-sectional study in Kenya, East Africa
por: Wangia, Ruth Nabwire, et al.
Publicado: (2019)

Assessment of independent comorbidities and comorbidity measures in predicting healthcare facility-onset Clostridioides difficile infection in Kenya
por: Mutai, Winnie C., et al.
Publicado: (2022)

Protocol of a randomised controlled trial characterising the immune responses induced by varicella-zoster virus (VZV) vaccination in healthy Kenyan women: setting the stage for a potential VZV-based HIV vaccine
por: Perciani, Catia T, et al.
Publicado: (2017)

Bombali Virus in Mops condylurus Bat, Kenya
por: Forbes, Kristian M., et al.
Publicado: (2019)

Hepatitis B Virus Incidence and Risk Factors Among Human Immunodeficiency Virus-1 Negative Men Who Have Sex With Men in Kenya
por: Wahome, Elizabeth, et al.
Publicado: (2016)

Detection of dengue virus type 2 of Indian origin in acute febrile patients in rural Kenya
por: Masika, Moses Muia, et al.
Publicado: (2020)

No Substantial Histopathologic Changes in Mops condylurus Bats Naturally Infected with Bombali Virus, Kenya
por: Kareinen, Lauri, et al.
Publicado: (2023)

Blunted IL17/IL22 and Pro-Inflammatory Cytokine Responses in the Genital Tract and Blood of HIV-Exposed, Seronegative Female Sex Workers in Kenya
por: Chege, Duncan, et al.
Publicado: (2012)

Retinoblastoma Referral Pattern in Kenya
por: Nyamori, Joseph M., et al.
Publicado: (2014)

High Prevalence of Multidrug-Resistant Clostridioides difficile Following Extensive Use of Antimicrobials in Hospitalized Patients in Kenya
por: Mutai, Winnie C., et al.
Publicado: (2021)

Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa
por: Jaoko, Walter, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_mjga4q55i1grn7u27tfuhp5qqu